As of 2026-06-26, GLOBUS MEDICAL INC (GMED) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.9%, relative volume 1.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ADR% (20d)avg daily range
2.9%
ATR(14)14-day EMA
$2.71
ATR%ATR as % of close
3.14%
Beta vs SPY90d rolling
0.70
1-ADR stoprisk from close $86.25
$83.71−2.9%
COMPUTED · AS OF 2026-06-26
Pattern read
GMED is in a stage 3 topping pattern, week 4. Currently in a 47-day base; basing ADR 3.3% (broad 2.9%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 2.8% / 5.9%.
Pure factual computation. Not a recommendation. See stage analysis.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
GMED ranks at the 63th percentile over 1 month, 39th percentile over 3 months, 45th percentile over 6 months, 76th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
GMED is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
GMED currently shows a 20-day average daily range (ADR%) of 2.9%, a 90-day beta versus the S&P 500 of 0.70. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes GMED's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what GMED has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
GMED most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-07. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
10y · since 2022
Best monthNovon averageavg +18.93% · 75% win · n 4
Worst monthFebon averageavg -7.14% · 50% win · n 4